AFM Portaal en AFM-website niet bereikbaar komend weekend
Vanaf vrijdag 4 oktober 21.00 uur tot zondag 6 oktober 21.00 uur is het AFM Portaal niet bereikbaar. Vanaf zaterdag 5 oktober 06.00 uur tot zondag 6 oktober 21.00 uur is de AFM-website niet bereikbaar.
DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
25 jun 2012 - 08:15
Statutaire naam
DSM B.V.
Titel
DSM completes acquisition of Kensey Nash and strengthens its biomedical business
Bericht
Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has
successfully completed the acquisition of Kensey Nash, through the merger of its subsidiary Biomedical
Acquisition Corporation with and into Kensey Nash. As a result of the merger, Kensey Nash is now an
indirect wholly owned subsidiary of DSM. The acquisition, announced on 3 May 2012, will strengthen
and complement DSM’s biomedical business, one of the three Emerging Business Areas of DSM. The
acquisition, for a total enterprise value of approximately USD 360 million, positions DSM Biomedical as
a profitable growth platform for DSM.
In the merger, each share of Kensey Nash common stock that was not acquired by DSM in the previously
concluded tender offer, other than those as to which holders exercise appraisal rights under Delaware law
and those held by DSM and Kensey Nash, have been converted into the right to receive the USD 38.50 price
per share in cash that was paid in the tender offer, without interest and less any required withholding
taxes.
Gerelateerde downloads
Datum laatste update: 06 oktober 2024